Tigecycline 50 mg/Vial Powder for Solution for Infusion (EU CTD Q4: 2020)
Product description
Tigecycline 50 mg/Vial Powder for Solution for Infusion Reference Product: Tygacil® / Pfizer
Description: Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunitand blocking entry of amino-acyl tRNA molecules into the A site of the ribosome. This prevents incorporation ofamino acid residues into elongating peptide chains. In general, Tigecycline is considered bacteriostatic. Tigecycline is indicated in adults and in children from the age of eight years for the treatment of the following infections: Complicated skin and soft tissue infections (cSSTI), excluding diabetic foot infections and Complicated intra-abdominal infections (cIAI). Tigecycline should be used only in situations where other alternative antibiotics are not suitable.
Dossier Status: On-going / EU CTD ready to file: Q4 2020
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Two (2) years
Batch Sizes: 11,790 vials
Pack Sizes: BT x 10 vials
Read more
Description: Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunitand blocking entry of amino-acyl tRNA molecules into the A site of the ribosome. This prevents incorporation ofamino acid residues into elongating peptide chains. In general, Tigecycline is considered bacteriostatic. Tigecycline is indicated in adults and in children from the age of eight years for the treatment of the following infections: Complicated skin and soft tissue infections (cSSTI), excluding diabetic foot infections and Complicated intra-abdominal infections (cIAI). Tigecycline should be used only in situations where other alternative antibiotics are not suitable.
Dossier Status: On-going / EU CTD ready to file: Q4 2020
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Two (2) years
Batch Sizes: 11,790 vials
Pack Sizes: BT x 10 vials
Specifications
| Categories | APIsAntibiotics; Finished Dosage FormsInjectables; Contract Services - Contract ServicesLyophilisation |
|---|---|
| Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
| Supplied from | Greece |
Products from other suppliers
❮
❯
-
VALSARIN 80/VALSARIN 160/VALSARIN 320
-
NURONORM
-
DERMOGEL NEW to treat inflammatory skin conditions
-
Anlitin (Levonorgestrel 1.5 mg) Tablet
-
Levocarnitine (LEKARNITIN) 1 G/5 ML SOLUTION FOR I.V. INJECTION
-
FOOD GRADE EPOXY COATING FOR INTERNAL POTABLE TANK PIPELINE - CLEAN TECH PW
-
Synatura Syrup
-
Ectoin® Allergy Eye Drops 2% - The innovation for treatment and prevention of allergic conjunctivitis symptoms
-
Kalmosan Skin Lotion
-
ComBE Five Pentavalent DTP-HepB-Hib
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation